PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Notably, this is the first report to our knowledge of the ABCC8 R653Q variant co-segregating with PNPLA3 I148M in MASLD patients, highlighting the novelty of our findings and supporting the rationale for integrated genomic and metabolic risk profiling in MASLD, particularly in patients with diabetes.